DASH vs IRMD · P/E 76, rev $13.72B vs P/E 51, rev $73.2M
DoorDash, Inc. Class A Common Stock (DASH) versus Iradimed Co (IRMD) — a side-by-side from cached financials, not a winner call.
DoorDash, Inc. Class A Common Stock (DASH) is a internet retail company listed on US.
Iradimed Co (IRMD) is a medical devices company listed on US.
Latest reported DASH revenue for 2025-12-31 was $13.72B. Net income was $935.0M. Revenue was up 27.9% from 2024-12-31 to 2025-12-31. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
Latest reported IRMD revenue for 2024-12-31 was $73.2M. Net income was $19.2M. Revenue was up 11.7% from 2023-12-31 to 2024-12-31. IRMD currently screens at market cap $1.19B and trailing P/E 50.9.
DASH currently screens at market cap $69.41B and trailing P/E 75.9. IRMD currently screens at market cap $1.19B and trailing P/E 50.9.
Not investment advice. Open the DASH and IRMD stock pages for the full models.
Not investment advice.